Cargando…

New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China

As reported previously in this newsletter, Fluence Corp Ltd's Aspiral™ family of decentralised, smart packaged wastewater treatment systems is being used worldwide, including countries such as China, where it is already being employed in numerous applications. Here, we briefly look at some rece...

Descripción completa

Detalles Bibliográficos
Autor principal: Atkinson, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270580/
http://dx.doi.org/10.1016/S0958-2118(20)30049-5
_version_ 1783541926760284160
author Atkinson, Simon
author_facet Atkinson, Simon
author_sort Atkinson, Simon
collection PubMed
description As reported previously in this newsletter, Fluence Corp Ltd's Aspiral™ family of decentralised, smart packaged wastewater treatment systems is being used worldwide, including countries such as China, where it is already being employed in numerous applications. Here, we briefly look at some recent developments in this country, where interest in this technology continues to grow. As an aside, the company has also provided an update regarding its operations in China and how they are potentially affected by the outbreak of the coronavirus.
format Online
Article
Text
id pubmed-7270580
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-72705802020-06-05 New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China Atkinson, Simon Membrane Technology Article As reported previously in this newsletter, Fluence Corp Ltd's Aspiral™ family of decentralised, smart packaged wastewater treatment systems is being used worldwide, including countries such as China, where it is already being employed in numerous applications. Here, we briefly look at some recent developments in this country, where interest in this technology continues to grow. As an aside, the company has also provided an update regarding its operations in China and how they are potentially affected by the outbreak of the coronavirus. 2020-03 2020-04-03 /pmc/articles/PMC7270580/ http://dx.doi.org/10.1016/S0958-2118(20)30049-5 Text en
spellingShingle Article
Atkinson, Simon
New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China
title New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China
title_full New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China
title_fullStr New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China
title_full_unstemmed New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China
title_short New strategic market segment and follow-on orders continue to strengthen Aspiral's position in China
title_sort new strategic market segment and follow-on orders continue to strengthen aspiral's position in china
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270580/
http://dx.doi.org/10.1016/S0958-2118(20)30049-5
work_keys_str_mv AT atkinsonsimon newstrategicmarketsegmentandfollowonorderscontinuetostrengthenaspiralspositioninchina